Can monitoring your glucose levels help you lose weight without the misery, or is it just another metric for biodata wonks to track? Rurik Bradbury, chief executive of Limbo, explains the science behind Silicon Valley's next big wearable bet.
Limbo, a weight-loss start up co-founded by Pat Phelan, has raised a €6m seed round. Basketball legend Shaquille O'Neal is on board, along with a host of successful Irish tech investors. But what actually is the technology that is promising so much?
The answer to this question depends on your definition of “good” or “bad”, your points of reference, and your units of comparison. This week Stephen Kinsella decided to have a debate about it. With himself.
Bruno Candès is a partner at the French private equity firm that owns the Mater Private Hospital, a group of 14 nursing homes and has just agreed to buy half of eir’s fibre network. He explains why Irish infrastructure fits Infravia’s strategy.
Many medical and other professionals have transferred their trade to a company. Now a doctor has been found personally liable for tax on fees earned through the new structure.
HealthBeacon helps patients self-administer medications. Now investors must weigh-up its tenfold growth predications, as it seeks to raise €25 million from a stock market flotation.
As an early-stage biotechnology company, Nuritas lives and dies by its investors' backing. A big new funding round that includes big names from the US, Europe and the UK is a vote of confidence in the company's prospects.
Nuritas operates at the cutting edge of biotechnology and has a blue-chip roster of shareholders and backers. But its losses are mounting and its auditors are referencing “material uncertainty”. Just what is going on?
Corporate veterinary groups have been “‘buying like blazes” in Ireland since a recent rule change, despite political pressure to keep them out. What does it mean for the business of being a vet?
A clinic owner claimed doctors and dental practitioners were contractors. Revenue recast them as employees. The subsequent dispute has far-reaching implications for medical and other professionals.
© 2023 Currency Media Limited
